Predictive models for lymph node metastases in patients with testicular germ cell tumors

被引:3
作者
Mao, Yun [1 ]
Hedgire, Sandeep [2 ]
Prapruttam, Duangkamon [2 ]
Harisinghani, Mukesh [2 ]
机构
[1] Chongqing Med Univ, Affiliated Hosp 1, Dept Radiol, Chongqing 400016, Peoples R China
[2] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Div Abdominal Imaging & Intervent, Boston, MA 02114 USA
来源
ABDOMINAL IMAGING | 2015年 / 40卷 / 08期
关键词
Testicular cancer; Lymph nodes; CT surveillance; Seminoma; Nonseminomatous germ cell tumors; STAGE-I SEMINOMA; PROGNOSTIC-FACTORS; MULTIVARIATE-ANALYSIS; RISK-FACTORS; CANCER; SURVEILLANCE; RELAPSE; MULTICENTER; NONSEMINOMA; CARCINOMA;
D O I
10.1007/s00261-015-0526-5
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Purpose: To develop predictive models for lymph node (LN) metastasis in testicular germ cell tumors. Materials and Methods: 291 patients with testicular germ cell tumors were included, which were divided into seminomatous and nonseminomatous groups. For screening the risk factors for LN metastasis, the tumor-related characteristics (including histopathological information and tumor markers) alpha fetoprotein and the lymph node-related features on CT were compared between metastatic cases and nonmetastatic cases. Two logistic regression models were built for each histological group, one depending on all tumor- and lymph node-related risk factors (Model 1) and another only on tumor-related factors (Model 2). Receivers operating characteristic curves were used to evaluate the predictive abilities of these models. Results: 117 positive nodes/regions were identified in 68 patients, including 51 metastases and 17 occult metastases. Based on the selected independent risk factors, the sensitivity, specificity, accuracy, positive predictive value, and negative predictive value of Models 1 and 2 in seminomatous and nonseminomatous groups were (95.5%, 95.3%, 95.3%, 77.8%, and 99.2%), (63.6%, 83.6%, 80.7%, 40.0%, and 93.0%), (93.5%, 94.7%, 94.3%, 89.6%, and 96.8%), and (89.1%, 44.2%, 58.9%, 43.6%, and 89.4%), respectively. Conclusion: Two predictive models for each seminomatous and nonseminomatous testicular tumor were established based on lymph node- and tumor-related risk factors. In patients with tumor and lymph node-related risk factors, regular CT surveillance is likely sufficient for predicting LN status, while in the patients without any tumor and lymph node-related risk factors a long interval-time CT follow-up should be considered. Additionally, right side tumors tend to involve contralateral LNs compared to left side ones. Positive inguinal LNs more frequently occur in patients with a history of groin surgery.
引用
收藏
页码:3196 / 3205
页数:10
相关论文
共 30 条
[1]   PROGNOSTIC FACTORS IN UNSELECTED PATIENTS WITH NONSEMINOMATOUS METASTATIC TESTICULAR CANCER - A MULTICENTER EXPERIENCE [J].
AASS, N ;
KLEPP, O ;
CAVALLINSTAHL, E ;
DAHL, O ;
WICKLUND, H ;
UNSGAARD, B ;
BALDETORP, L ;
AHLSTROM, S ;
FOSSA, SD .
JOURNAL OF CLINICAL ONCOLOGY, 1991, 9 (05) :818-826
[2]  
Albers P, 2012, ACTAS UROL ESP, V36, P127, DOI [10.1016/j.acuroe.2012.05.002, 10.1016/j.acuro.2011.06.017]
[3]   Risk factors for relapse in clinical stage I nonseminomatous testicular germ cell tumors: Results of the German Testicular Cancer Study Group Trial [J].
Albers, P ;
Siener, R ;
Kliesch, S ;
Weissbach, L ;
Krege, S ;
Sparwasser, C ;
Schulze, H ;
Heidenreich, A ;
de Riese, W ;
Loy, V ;
Bierhoff, E ;
Wittekind, C ;
Fimmers, R ;
Hartmann, M .
JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (08) :1505-1512
[4]   Risk-adapted management for patients with clinical stage I seminoma:: The second Spanish germ cell cancer cooperative group study [J].
Aparicio, J ;
Germà, JR ;
del Muro, XG ;
Maroto, P ;
Arranz, JA ;
Sáenz, A ;
Barnadas, A ;
Dorca, J ;
Gumà, J ;
Olmos, D ;
Bastús, R ;
Carles, J ;
Almenar, D ;
Sánchez, M ;
Paz-Ares, L ;
Satrústegui, JJ ;
Mellado, B ;
Balil, A ;
López-Brea, M ;
Sánchez, A .
JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (34) :8717-8723
[5]  
BOSL GJ, 1983, CANCER RES, V43, P3403
[6]   Risk factors for relapse in patients with clinical stage I testicular nonseminomatous germ cell tumors [J].
Dong, Pei ;
Liu, Zhuo-Wei ;
Li, Xiang-Dong ;
Li, Yong-Hong ;
Yao, Kai ;
Wu, Song ;
Qin, Zi-Ke ;
Han, Hui ;
Zhou, Fang-Jian .
MEDICAL ONCOLOGY, 2013, 30 (01)
[7]  
DROZ JP, 1988, CANCER-AM CANCER SOC, V62, P564, DOI 10.1002/1097-0142(19880801)62:3<564::AID-CNCR2820620321>3.0.CO
[8]  
2-A
[9]   STAGE-I NONSEMINOMATOUS GERM-CELL TESTICULAR-TUMOR - PREDICTION OF METASTATIC POTENTIAL BY PRIMARY HISTOPATHOLOGY [J].
FUNG, CY ;
KALISH, LA ;
BRODSKY, GL ;
RICHIE, JP ;
GARNICK, MB .
JOURNAL OF CLINICAL ONCOLOGY, 1988, 6 (09) :1467-1473
[10]   Diagnostic Value of Multislice Computed Tomography and Magnetic Resonance Imaging in the Diagnosis of Retroperitoneal Spread of Testicular Cancer: A Literature Review [J].
Hansen, J. ;
Jurik, A. G. .
ACTA RADIOLOGICA, 2009, 50 (09) :1064-1070